Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Subject: Liver Disease - PUBLISHED VIA PLOS ONE
Author(s):
Hegde VL, Nagarkatti PS, Nagarkatti M
View Source >>
Related Studies:
The endocannabinoid system and liver diseases.
Published via Journal of Neuroendocrinology
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
Published via Author Manuscript
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
Published via British Journal of Pharmacology
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
Published via European Journal of Pharmacology
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
Published via Cell Death & Disease